NOXOPHARM LIMITED — Capital/Financing Update 2016

Aug 7, 2016

MARKET RELEASE

8 August 2016

Noxopharm Limited

PRE-QUOTATION DISCLOSURE

Noxopharm Limited (the “Company”) was admitted to the Official List of ASX Limited on Friday, 5 August 2016.

The following information is released as pre-quotation disclosure.

1. A distribution schedule of the number of holders in each class of security to be quoted, setting out the number of holders in the following categories: 1 – 1,000

   • 1,001 – 5,000

   • 5,001 – 10,000 10,001 – 100,000 100,001 and over

2. A statement setting out the names of the 20 largest holders of each class of securities to be quoted, including the number and percentage of each class of securities held by those holders.

3. The Company’s Appendix 1A and Information Form and Checklist.

4. The Prospectus.

5. The Company’s constitution.

6. The Company’s reviewed accounts for the period 27 October 2015 to 31 March 2016.

www.asx.com.au (03) 9617 8772 Customer service 13 12 79 cheng.tang@asx.com.au

Level 4, North Tower, Rialto 525 Collins Street Melbourne VIC 3000

ASX Compliance Pty Limited ABN 26 087 780 489

1. The Company’s securities trading policy.

2. A statement setting out the number of securities subject to ASX restrictions and the restriction period applied to those securities.

3. The full terms and conditions of the Company’s options on issue.

4. The full terms and conditions of the Company’s performance shares on issue.

5. A statement setting out the Company’s updated capital structure and securities on issue.

Security Code: NOX

Cheng Tang

ADVISER, LISTINGS (MELBOURNE)

2/2